Accessibility StatementSkip Navigation CANTON, Conn., Nov. 10, 2025 /PRNewswire/ --Â Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today reported financial results for the third quarter ended September 30, 2025. Q3 2025 Financial Highlights (Compared to Q3 2024) "Sales have faced headwinds this year from a slow distributor ramp-up and temporary market share shifts, but through Q3, we're steadily catching up to 2024 levels and building a stronger foundation for sust ...